Clinical trials of medical devices: the changing scene
This article was originally published in Clinica
Executive Summary
Improvements in communication and transportation technologies mean that the traditional locations for R&D are being challenged by up-and-coming sites. Here, Gerard Dunne, managing director of New Zealand-based contract research organisation BELTAS, lays out the advantages of conducting clinical trials in non-traditional countries